Na Yang

Title: Na Yang - Innovator in Pharmaceutical Chemistry

Introduction

Na Yang is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel anti-tumor medications. Her innovative work has led to the creation of a unique class of compounds known as rapalogs.

Latest Patents

Na Yang holds a patent for "Rapamycin carbonic ester analogues, pharmaceutical compositions, preparations and uses thereof." This patent describes rapalogs of formula I, which include pharmaceutically acceptable salts, pharmaceutical compositions, and preparation methods. The rapalogs developed by Yang exhibit enhanced water solubility and improved pharmacological and pharmacokinetic properties compared to traditional rapamycin. By introducing hydrophilic and polar groups, such as hydroxyl, these compounds show promise as effective anti-tumor medicaments.

Career Highlights

Na Yang is affiliated with the Chinese Academy of Sciences, where she conducts her research and development activities. Her work has garnered attention for its potential impact on cancer treatment and pharmaceutical advancements. With a focus on improving drug solubility and efficacy, Yang continues to push the boundaries of pharmaceutical innovation.

Collaborations

Na Yang collaborates with esteemed colleagues, including Jianping Zuo and Yangming Zhang. These partnerships enhance her research efforts and contribute to the advancement of their shared goals in pharmaceutical development.

Conclusion

Na Yang's contributions to pharmaceutical chemistry, particularly through her innovative rapalogs, highlight her role as a key inventor in the field. Her work not only advances scientific knowledge but also holds the potential to improve cancer treatment options.